AP NEWS

New Research Coverage Highlights Titan International, Revance Therapeutics, Ryerson Holding, Iridium Communications, Chase, and Peoples — Consolidated Revenues, Company Growth, and Expectations for 2018

August 7, 2018

NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Titan International, Inc. (NYSE:TWI), Revance Therapeutics, Inc. (NASDAQ:RVNC), Ryerson Holding Corporation (NYSE:RYI), Iridium Communications Inc (NASDAQ:IRDM), Chase Corporation (NYSE:CCF), and Peoples Bancorp Inc. (NASDAQ:PEBO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TWI DOWNLOAD: http://Fundamental-Markets.com/register/?so=TWI RVNC DOWNLOAD: http://Fundamental-Markets.com/register/?so=RVNC RYI DOWNLOAD: http://Fundamental-Markets.com/register/?so=RYI IRDM DOWNLOAD: http://Fundamental-Markets.com/register/?so=IRDM CCF DOWNLOAD: http://Fundamental-Markets.com/register/?so=CCF PEBO DOWNLOAD: http://Fundamental-Markets.com/register/?so=PEBO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Titan International, Inc. (NYSE:TWI), Revance Therapeutics, Inc. (NASDAQ:RVNC), Ryerson Holding Corporation (NYSE:RYI), Iridium Communications Inc (NASDAQ:IRDM), Chase Corporation (NYSE:CCF), and Peoples Bancorp Inc. (NASDAQ:PEBO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 3rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TITAN INTERNATIONAL, INC. (TWI) REPORT OVERVIEW

Titan International’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Titan International reported revenue of $425.38MM vs $357.50MM (up 18.99%) and basic earnings per share $0.23 vs -$0.18. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Titan International reported revenue of $1,468.92MM vs $1,265.50MM (up 16.07%) and basic earnings per share -$1.12 vs -$0.87. Titan International is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.09. The estimated EPS forecast for the next fiscal year is $0.82 and is expected to report on February 22nd, 2019.

To read the full Titan International, Inc. (TWI) report, download it here: http://Fundamental-Markets.com/register/?so=TWI

-----------------------------------------

REVANCE THERAPEUTICS, INC. (RVNC) REPORT OVERVIEW

Revance Therapeutics’ Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Revance Therapeutics reported revenue of $0.19MM vs $0.08MM (up 157.33%) and basic earnings per share -$0.97 vs -$0.94. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Revance Therapeutics reported revenue of $0.26MM vs $0.30MM (down 12.67%) and basic earnings per share -$4.01 vs -$3.18. Revance Therapeutics is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.01. The estimated EPS forecast for the next fiscal year is -$4.05 and is expected to report on February 27th, 2019.

To read the full Revance Therapeutics, Inc. (RVNC) report, download it here: http://Fundamental-Markets.com/register/?so=RVNC

-----------------------------------------

RYERSON HOLDING CORPORATION (RYI) REPORT OVERVIEW

Ryerson Holding’s Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Ryerson Holding reported revenue of $1,057.10MM vs $875.40MM (up 20.76%) and basic earnings per share $0.47 vs $0.02 (up 2,250.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ryerson Holding reported revenue of $3,364.70MM vs $2,859.70MM (up 17.66%) and basic earnings per share $0.46 vs $0.55 (down 16.36%). Ryerson Holding is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.05. The estimated EPS forecast for the next fiscal year is $2.00 and is expected to report on March 4th, 2019.

To read the full Ryerson Holding Corporation (RYI) report, download it here: http://Fundamental-Markets.com/register/?so=RYI

-----------------------------------------

IRIDIUM COMMUNICATIONS INC (IRDM) REPORT OVERVIEW

Iridium Communications’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Iridium Communications reported revenue of $134.93MM vs $111.60MM (up 20.90%) and basic earnings per share -$0.06 vs $0.21. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Iridium Communications reported revenue of $448.05MM vs $433.64MM (up 3.32%) and basic earnings per share $2.23 vs $1.00 (up 123.00%). Iridium Communications is expected to report earnings on October 25th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the next fiscal year is -$0.37 and is expected to report on February 28th, 2019.

To read the full Iridium Communications Inc (IRDM) report, download it here: http://Fundamental-Markets.com/register/?so=IRDM

-----------------------------------------

CHASE CORPORATION (CCF) REPORT OVERVIEW

Chase’s Recent Financial Performance

For the three months ended May 31st, 2018 vs May 31st, 2017, Chase reported revenue of $78.92MM vs $64.90MM (up 21.60%) and basic earnings per share $1.44 vs $1.27 (up 13.39%). For the twelve months ended August 31st, 2017 vs August 31st, 2016, Chase reported revenue of $252.56MM vs $238.09MM (up 6.08%) and basic earnings per share $4.49 vs $3.55 (up 26.48%). Chase is expected to report earnings on October 29th, 2018. The report will be for the fiscal period ending August 31st, 2018.

To read the full Chase Corporation (CCF) report, download it here: http://Fundamental-Markets.com/register/?so=CCF

-----------------------------------------

PEOPLES BANCORP INC. (PEBO) REPORT OVERVIEW

Peoples’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Peoples reported interest income of $37.77MM vs $31.21MM (up 21.02%) and basic earnings per share $0.41 vs $0.54 (down 24.07%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Peoples reported interest income of $126.53MM vs $115.44MM (up 9.60%) and basic earnings per share $2.12 vs $1.72 (up 23.26%). Peoples is expected to report earnings on October 23rd, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.53. The estimated EPS forecast for the next fiscal year is $2.85 and is expected to report on January 22nd, 2019.

To read the full Peoples Bancorp Inc. (PEBO) report, download it here: http://Fundamental-Markets.com/register/?so=PEBO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

AP RADIO
Update hourly